gov. andrew cuomo announced a new lyme and other tick-borne disease control plan tuesday to keep the public informed and free of tick-borne diseases..
.
stephen silberstein, md, director, jefferson university headache center....eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies..
follow dailymail